• Product nameAnti-Noggin antibody
    See all Noggin primary antibodies
  • Description
    Rabbit polyclonal to Noggin
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    Synthetic peptide corresponding to an internal sequence of Human Noggin.

  • Positive control
    • Human hippocampus tissue lysate



Our Abpromise guarantee covers the use of ab93330 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesWB: 1/1000 - 1/2000. Predicted molecular weight: 26 kDa.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionEssential for cartilage morphogenesis and joint formation. Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite.
    • Involvement in diseaseDefects in NOG are a cause of symphalangism proximal syndrome (SYM1) [MIM:185800]. SYM1 is characterized by the hereditary absence of the proximal interphalangeal (PIP) joints (Cushing symphalangism). Severity of PIP joint involvement diminishes towards the radial side. Distal interphalangeal joints are less frequently involved and metacarpophalangeal joints are rarely affected whereas carpal bone malformation and fusion are common. In the lower extremities, tarsal bone coalition is common. Conducive hearing loss is seen and is due to fusion of the stapes to the petrous part of the temporal bone.
      Defects in NOG are the cause of multiple synostoses syndrome type 1 (SYNS1) [MIM:186500]; also known as synostoses, multiple, with brachydactyly/symphalangism-brachydactyly syndrome. SYNS1 is characterized by tubular-shaped (hemicylindrical) nose with lack of alar flare, otosclerotic deafness, and multiple progressive joint fusions commencing in the hand. The joint fusions are progressive, commencing in the fifth proximal interphalangeal joint in early childhood (or at birth in some individuals) and progressing in an ulnar-to-radial and proximal-to-distal direction. With increasing age, ankylosis of other joints, including the cervical vertebrae, hips, and humeroradial joints, develop.
      Defects in NOG are the cause of tarsal-carpal coalition syndrome (TCC) [MIM:186570]. TCC is an autosomal dominant disorder characterized by fusion of the carpals, tarsals and phalanges, short first metacarpals causing brachydactyly, and humeroradial fusion. TCC is allelic to SYM1, and different mutations in NOG can result in either TCC or SYM1 in different families.
      Defects in NOG are a cause of stapes ankylosis with broad thumb and toes (SABTS) [MIM:184460]; also known as Teunissen-Cremers syndrome. SABTS is a congenital autosomal dominant disorder that includes hyperopia, a hemicylindrical nose, broad thumbs, great toes, and other minor skeletal anomalies but lacked carpal and tarsal fusion and symphalangism.
      Defects in NOG are the cause of brachydactyly type B2 (BDB2) [MIM:611377]. BDB2 is a subtype of brachydactyly characterized by hypoplasia/aplasia of distal phalanges in combination with distal symphalangism, fusion of carpal/tarsal bones, and partial cutaneous syndactyly.
    • Sequence similaritiesBelongs to the noggin family.
    • Cellular localizationSecreted.
    • Information by UniProt
    • Database links
    • Alternative names
      • Nog antibody
      • NOGG_HUMAN antibody
      • Noggin antibody
      • SYM 1 antibody
      • SYM1 antibody
      • Symphalangism 1 (proximal) antibody
      • Synostoses (multiple) syndrome 1 antibody
      • SYNS 1 antibody
      • SYNS1 antibody
      see all

    Anti-Noggin antibody images

    • All lanes : Anti-Noggin antibody (ab93330) at 1/1000 dilution

      Lane 1 : Human hippocampus tissue lysate
      Lane 2 : Human hippocampus tissue lysate with immunizing paptide

      Lysates/proteins at 20 µg per lane.

      AP-conjugated secondary antibody at 1/5000 dilution

      Predicted band size : 26 kDa

    References for Anti-Noggin antibody (ab93330)

    ab93330 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab93330.
    Please use the links above to contact us or submit feedback about this product.